Human inherited CCR2 deficiency underlies progressive polycystic lung disease
Pulmonary and Respiratory Medicine
Receptors, CCR2
Chemokine receptor
Human Inborn Errors
Immunology
610
Trained Immunity in Health and Disease
macrophage
[SDV.BC]Life Sciences [q-bio]/Cellular Biology
Pulmonary Alveolar Proteinosis
Alveolar
Monocyte
Article
618
cystic lung disease
Receptors
Sciences du Vivant [q-bio]/Biologie cellulaire
Macrophages, Alveolar
Health Sciences
Humans
chemotaxis
Child
Neonatal Lung Development and Respiratory Morbidity
Biology
Lung
Internal medicine
Immunology and Microbiology
JGM
Macrophages
Genetic Basis of Primary Immunodeficiency Disorders
FOS: Clinical medicine
Life Sciences
PAP
Immune system
Chemokine
Reinfection
monocyte
Medicine
CCR2
recurrent infection
Pulmonary alveolar proteinosis
DOI:
10.1016/j.cell.2023.11.036
Publication Date:
2023-12-28T15:28:07Z
AUTHORS (74)
ABSTRACT
We describe a human lung disease caused by autosomal recessive, complete deficiency of the monocyte chemokine receptor C-C motif 2 (CCR2). Nine children from five independent kindreds have pulmonary alveolar proteinosis (PAP), progressive polycystic disease, and recurrent infections, including bacillus Calmette Guérin (BCG) disease. The CCR2 variants are homozygous in six patients compound heterozygous three, all loss-of-expression loss-of-function. They abolish CCR2-agonist ligand (CCL-2)-stimulated Ca2+ signaling migration monocytic cells. All high blood CCL-2 levels, providing diagnostic test for screening with unexplained or mycobacterial Blood myeloid lymphoid subsets interferon (IFN)-γ- granulocyte-macrophage colony-stimulating factor (GM-CSF)-mediated immunity unaffected. CCR2-deficient monocytes macrophage-like cells normal gene expression profiles functions. By contrast, macrophage counts about half. Human is genetic etiology PAP, infections impaired CCL2-dependent to lungs infected tissues.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (108)
CITATIONS (34)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....